Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb;34(2):221-222.
doi: 10.1038/s41433-019-0707-5. Epub 2019 Nov 26.

Comparison of vascular endothelial growth factor inhibitors on macular oedema secondary central retinal vein occlusion

Kelvin Yi Chong Teo  1   2 , Aditi Mohla  1   3 , Chui Ming Gemmy Cheung  4   5   6
Affiliations
Editorial

Comparison of vascular endothelial growth factor inhibitors on macular oedema secondary central retinal vein occlusion

Kelvin Yi Chong Teo et al. Eye (Lond). 2020 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117:1124–33.e1121. doi: 10.1016/j.ophtha.2010.02.022. - DOI - PubMed
    1. Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology. 2012;119:1184–9. doi: 10.1016/j.ophtha.2012.01.022. - DOI - PubMed
    1. Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155:429–37.e427. doi: 10.1016/j.ajo.2012.09.026. - DOI - PubMed
    1. Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, et al. Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO Study. Ophthalmology. 2014;121:202–8. doi: 10.1016/j.ophtha.2013.08.012. - DOI - PubMed
    1. Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology. 2016;123:1351–9. doi: 10.1016/j.ophtha.2016.02.022. - DOI - PMC - PubMed

Publication types

MeSH terms